Prevalence and Disability of Peripheral Neuropathy in Patients With Waldenström's Macroglobulinemia
Peripheral neuropathy (PN) is considered a frequent complication of Waldenström's macroglobulinemia (WM).
Peripheral neuropathy (PN) is considered a frequent complication of Waldenström's macroglobulinemia (WM). Establishing a causal relationship between PN and WM is complicated by confounding factors such as age‐related axonal loss and diabetes. This scoping review aims to summarize the current evidence on WM‐associated PN with a focus on prevalence, phenotype, and disability.
PN in WM can significantly impair quality of life; understanding its prevalence, phenotype, and disability burden is essential for developing effective monitoring and treatment strategies.
Bizonyítékszint: Állatkísérletes. Állatmodellben vizsgálták.
Kapcsolódó jelek
- Waldenström Macroglobulinemia Clinical Trials
- Cost-effectiveness of zanubrutinib versus ibrutinib as first-line treatment for patients with Waldenström macroglobulinemia in China
- European Consortium for Waldenström's Macroglobulinemia
- Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 2- Focus on Therapy
- The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?